Ischemia Technologies Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $22.4M
Latest Deal Amount

Ischemia Technologies General Information

Description

Developer of vitro diagnostic products. The company develops, manufactures and markets diagnostic devices for vitro diagnostic tests specifically aimed at cardiac ischemia involving insufficient blood supply to the heart due to partial or complete obstruction of a coronary artery, thereby enabling medical professionals to address acute clinical conditions that require an immediate diagnosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • Arvada, CO 80003
  • United States
+1 (720) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ischemia Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 14-Feb-2005 $22.4M 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 09-Nov-2004 00.000 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 29-Aug-2003 00.000 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Jul-2001 000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 21-Dec-2000 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 19-Mar-1999 $4.47M $6.47M 000.00 Completed Startup
1. Seed Round $2M $2M Completed Startup
To view Ischemia Technologies’s complete valuation and funding history, request access »

Ischemia Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.00 00.00 00.00 00.000
Series C 0,000,000 00.000000 00 00 00 0.000
Series B 5,500,000 $0.001000 8% $2 $2 $2 27.04%
Series A 2,233,809 $0.001000 8% $2 $2 $2 10.98%
To view Ischemia Technologies’s complete cap table history, request access »

Ischemia Technologies Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Global Venture Alliance Accelerator/Incubator Minority 000 0000 000000 0
KB Partners Venture Capital Minority 000 0000 000000 0
Piedmont Venture Partners Venture Capital Minority 000 0000 000000 0
Plymouth Growth Venture Capital Minority 000 0000 000000 0
Quest Capital Partnership Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »